ChemCon Passes its Fourth FDA Inspection
ChemCon passes its fourth FDA inspection in the 17-year history of the company.
ChemCon, a Freiburg, Germany-based contract research company that offers custom synthesis of APIs and fine chemicals, has announced that it successfully passed an FDA inspection.
The March 2014 inspection for GMP compliance was the fourth in the 17-year history of the company. The inspection examined all quality assurance systems of the company relating to production, equipment,manufacturing facilities, materials, and quality controls. No form 483 was issued, the quality systems were considered acceptable, and the inspection was classified as no action indicated, the company reports.
Source: ChemCon
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.
